June 25, 2012 (Seattle, Washington)— Many patients on ventricular-assist-device (VAD) support are at such low risk of adverse events that they ought not to be in the highest-priority category for a ...

Please provide your email address to receive an email when new articles are posted on . The FDA designated Abbott’s recall of its LVAD communication system as class I, the most serious type. Status of ...

Medtronic announced it has received a breakthrough device designation from the FDA for its fully implantable left ventricular assist device for patients with advanced HF. Perspective from Frank Smart, ...

Abbott is recalling a communication system that monitors heart failure patients implanted with its Heartmate 3 left ventricular assist device (LVAD) due to a risk that the system could unexpectedly ...

NEW YORK--(BUSINESS WIRE)--The U.S. Food and Drug Administration has granted conditional approval to conduct an Investigational Device Exemption study of Jarvik Heart’s new miniature Left Ventricular ...

Ventricular assist devices are mechanical pumps that take over the function of the damaged ventricle in order to re-establish normal hemodynamics and end-organ blood flow. In addition, VADs unload the ...

The Sandra Atlas Bass Heart Hospital at North Shore University Hospital (NSUH) is the first on Long Island to implant the newest generation of a left ventricular assist device (LVAD) that provides ...

The advanced heart failure team at Virtua Our Lady of Lourdes Hospital in Camden has successfully performed the health system’s first left ventricular assist device (LVAD) implantation. LVADs are ...

Mornings spent together for Barbara and Walter Harsche are truly a gift. Three years ago, Walter was diagnosed with congestive heart failure and was told he needed a heart transplant. "The thought of ...